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INTRODUCTION
The use of medicines to treat common complaints, 
such as headache, stomachache, difficulties in getting 
to sleep and nervousness, is widespread among adoles-
cents. Several studies have found that medicine use is 
increasing, and have noted differences regarding age, 
gender and the types of medicines taken [1-5].
Overall, the use of medicine and the prevalence of 
frequent complaints are much higher among girls than 
boys [6-8]. Studies have shown an increasing use of 
medicine for headache and stomachache in girls [1, 2, 
5, 8] and a decreasing use of medicines for nervousness 
and getting to sleep among boys [2, 5]. 
This behavior is supported by the greater accessibility 
and availability of medicines, changes in pharmaceuti-
cal regulations and the attitude of parents, who are the 
primary source of medicines [1, 5, 6]. Moreover, An-
dersen et al. [9] suggest that the use of medicines in 
adolescence continues into adulthood, underlining the 
need for proper use among adolescents. Adolescence 
has been identified by the World Health Organization 
(WHO) as the age from 10 to 19 years, and is a key 
period of human growth [10].
As adolescents have poor knowledge of medicines, it 
seems important, from a public health point of view, 
to instruct them in proper medicine use and to study 
trends in medicine use in target groups [1, 7, 9]. 
Although in-country studies have evaluated such 
trends, the results are difficult to compare, owing to dif-
ferences in study populations, data collection and mea-
surements [1]. The international Health Behaviour in 
School-aged Children (HBSC) study, which is based on 
a unified methodology and covers European and North 
American countries, is a unique tool for collecting data 
on medicine use among adolescents [6].
The aim of the present survey was to estimate the 
prevalence of recurrent specific complaints, headache, 
stomachache, difficulties in getting to sleep and ner-
vousness, among 15-year-old adolescents in Tuscany 
over three years (2006, 2010 and 2014) and that of 
medicine use to treat these specific symptoms among 
boys and girls.
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Abstract
Background. The use of medicines to treat common complaints, such as headache, 
stomachache, difficulty in getting to sleep and nervousness, is widespread among ado-
lescents, and is increasing. The aim of this survey was to estimate the prevalence of 
recurrent specific complaints among 15-year-old adolescents in Tuscany over three years 
(2006, 2010 and 2014) and that of medicine use to treat these complaints among boys 
and girls.
Methods. The present study  is based on data from the Tuscan HBSC studies at three 
time points (2006, 2010 and 2014), which involved 2830 adolescents, aged 15 years old 
(1395 boys and 1435 girls).
Results. Overall, the data confirm that adolescents who suffer from recurrent complaints 
are more likely to use medicines. The prevalence rates of all complaints were higher in 
girls than in boys in the three years considered. Over the whole period, headache, stom-
achache and difficulty in getting to sleep increased in girls, while boys displayed signifi-
cant decrease in nervousness and stomachache. 
Conclusion. Our findings underline the fact that the use of medicines in adolescence is 
a public health concern and constitutes an emerging issue that needs greater attention 
and investigation on the part of scientific research.
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METHODS
Study design and population
The data presented in this study were taken from 
HBSC surveys conducted in Tuscany over three years 
(2006, 2010 and 2014). The aims and theoretical 
framework of the international and Italian studies are 
described in detail [11-13]. 
The methods used to gather these data are described 
in detail elsewhere [11, 12].
Parental consent to participation in the survey was 
required. The Ethics Committee of the National Insti-
tute of Health (Comitato Etico dell’Istituto Superiore 
di Sanità), which approved the protocol, agreed to the 
use of an opt-out consent form, which implied that a 
child would be included by default unless his or her par-
ents chose to “opt-out” by explicitly refusing consent. 
Data collection was anonymous and the demographic 
information collected (gender, year and month of birth, 
nationality, nationality of parents) does not permit 
identification of the individual adolescent. HBSC data 
are collected every fourth year on children aged 11, 13 
and 15 out of a random sample of schools (also known 
as cluster sampling).
The HBSC study uses an anonymous self-adminis-
tered questionnaire, which complies with international 
standards and is distributed in schools [13]. All member 
countries are involved in a continuous process of de-
velopment and validation of the questionnaire. Several 
studies on many topics  have demonstrated the validity 
of the questionnaire.
Sample
Identical protocols, in terms of target groups, sam-
pling and data collection, were used in all surveys. Sys-
tematic cluster sampling (schools), stratified by admin-
istrative district, was applied in each of the three waves 
from which the sample was drawn. Only 15-year-old 
adolescents (1175 in 2006, 901 in 2010, 754 in 2014) 
were included in this study, as adolescents of this age 
are more independent in their use of medicines. The 
distribution of participants, in terms of age and sex, was 
similar in all 3 surveys; additional details of the Italian 
HBSC study can be found elsewhere [12, 13].
Instrument and variables
An anonymous, structured questionnaire was admin-
istered in classrooms by trained personnel.
Symptoms
The frequency of the symptoms considered (head-
ache, stomachache, difficulties in getting to sleep and 
nervousness) was measured on a scale that ranged from 
almost “every day” to “rarely or never”. Each symptom 
was dichotomized as “recurrent”, if occurring at least 
weekly, and “not recurrent” otherwise.
Medicine use
We considered only medications used to treat specific 
symptoms (e.g. headache and medicines for headache). 
The scale used to measure these value was: “yes, once”, 
“yes, more than once” and “no”. This scale was dichoto-
mized into “yes” and “no”. We have considered as cat-
egory “Yes” the cumulative responses “Yes, once” and 
“Yes, more than once”, as category “No”, otherwise.
Statistical analysis
To compare proportions between two or more groups, 
we used the chi-square test. In case of more than two 
groups, subsequently, in the case of a significant differ-
ence, we applied Bonferroni’s correction to calculate the 
p-value for multiple comparisons. A chi-square test for 
trend was implemented in order to estimate time trend 
analysis for the prevalence of recurrent complaints. To 
estimate the OR (IC 95%), we used two different Lo-
gistic Regression’s models: one for each time period 
(2006, 2010, 2014) and “All year” and one for Trend 
(2006-2010, 2010-2014, 2006-2014). In both cases we 
stratified the analysis for gender and we used the values 
“no recurrent” for symptom variables, “no” for medicine 
variables and the lowest level for time period (2006 and 
2010) as the reference category. 
In the first model, we used “use of medicine” (yes or 
not) as dependent variable and “status of complaints” 
(no recurrent or recurrent) as independent variable. In 
the second model we have the same dependent variable 
and as independent variable the year of survey, selecting 
only the subjects with recurrent complaints. The odds 
represents the constant effect of a predictor X, on the 
likelihood that one outcome will occur.
SPSS software, version 20.0, was used to carry out all 
statistical analyses. For all analyses, a statistical signifi-
cance level of 5% was used.
RESULTS  
The survey evaluated four specific complaints – head-
ache, stomachache, difficulty in getting to sleep and 
nervousness – among Tuscan boys and girls over three 
time-periods (2006, 2010, 2014). Overall, the number 
of respondents was almost equivalent between girls 
and boys, with a slight prevalence of girls in 2006 (602 
females vs 571 males) and 2014 (398 females vs 356 
males).
A progressive reduction in the numbers of respon-
dents over the whole period 2006-2014 was observed 
for both genders (Table 1), the causes of which will be 
investigated in the next HBSC Italian survey. 
Differences by gender are shown in Table 1 as preva-
lence rates of each recurrent complaint considered. In 
each survey, girls systematically displayed higher preva-
lence rates of all complaints than boys, with statistically 
significant differences between the genders.
For example, in 2006, only 29.3% of boys reported 
suffering from headache, as opposed to 54.6% of girls (a 
statistically significant difference of about 25 percent-
age points, p < 0.01). In the same year, 32.6% of girls 
stated that they suffered from stomachache, as against 
21.6% of males (a difference of about 25 percentage 
points; p < 0.01), and again, about 27% of girls reported 
having difficulty in getting to sleep, versus 20% of males 
(a difference of about 7 percentage points; p < 0.01), 
the smallest difference between the genders. Finally, 
the prevalence of nervousness in the same year was 
higher among females than males (a difference of about 
16 percentage points, p < 0.01).
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From 2006 to 2014, the time trend analysis showed 
a progressive, albeit moderate, increase in headache in 
girls (from 54.6% in 2006 to 56.5% in 2010 to 61.9% 
in 2014 [p = 0.025]), but not in boys (29.3% in 2006, 
30.1% in 2010, 27.5 % in 2014) (analysis was per-
formed, but the p-values are not showed).
Concerning stomachache, the data reveal a marked 
decrease in boys, especially between 2006 and 2014 
(from 21.6% to 14.7%, p = 0.015) and a considerable 
increase in girls: from 32.6% in 2006 to 41.5% in 2010 
to 38.8% in 2014, p = 0.024 (Table 1).
In each of the three years, girls systematically dis-
played higher prevalence rates of recurrent complaints 
than boys. Over the whole period, the prevalence of ner-
vousness remained fairly constant among girls (2006 = 
75.8%; 2010 = 74.3%; 2014 = 75.6%), while significant 
decrease was observed in boys (2006 = 59.5%; 2010 = 
56.5%; 2014 = 52.4%, [p = 0.035]). 
Finally, the complaint “stomachache” showed a sta-
tistically significant trend over the whole study period 
among both girls (p = 0.01) and boys (p = 0.01). The 
trend is characterized by an increase for girls and de-
crease for boys.
Difficulty in getting to sleep displayed a significant in-
crease among girls between 2006 and 2014 (p = 0.004). 
The prevalence and odds ratio (95% CI) of medicine 
use for the symptoms analyzed among 15-year-old ado-
lescents with recurrent complaints, by gender, in 2006, 
2010 and 2014 are shown in Table 2.
In both boys and girls, and in all years, the risk (OR) 
of medicine use was about four/five times greater 
among those who suffered from headache than those 
who did not. Similarly, the probability of taking medi-
cine to treat stomachache was about three times greater 
among both boys and girls who suffered from stomach-
ache than among those who did not. 
With regard to difficulty in getting to sleep and ner-
vousness, unlike the other symptoms, the use of medi-
cine differed markedly between boys and girls. In all 
years, the risk of medicine use was about four times 
greater among boys with difficulty in getting to sleep 
than among boys who did not have this problem. Among 
girls, however, the risk of taking medicine in order to get 
to sleep was about nine times greater among those with 
this problem than among those who did not have dif-
ficulty getting to sleep. Similarly, in all years, boys who 
complained of nervousness were about four times more 
likely to take medicine to treat this complaint than boys 
who did not suffer from this complaint. Among girls, 
however, the probability was about ten higher. 
Analysis of the trend in medicine use in the periods 
2006-2010, 2010-2014 and 2006-2014 did not reveal a 
major increase among boys, except for the period 2006-
2010, in which a 4.44-fold increase in the odds of medi-
cine use for difficulties in getting to sleep was recorded. 
Among girls, however, the probability of medicine use for 
headache and nervousness increased by 1.45 times and 
1.73 times, respectively, in 2010-2014 and 2006-2014. 
The complaint for which most respondents used 
pharmaceutical drugs was headache (60.5%), with an 
increase, albeit not statistically significant, of five per-
centage points from 2010 to 2014. Nevertheless, the 
highest ORs were observed with regard to difficulty in 
getting to sleep; those who suffered from this complaint 
were about six times more likely to treat the problem 
with drugs than those who did not have this difficulty. 
From 2006 to 2010, this value rose, but subsequently 
declined in 2014 (3.87). This trend was more marked 
in girls than in boys. Moreover, a significant rising trend 
was seen in the number of girls suffering from insomnia 
between 2006 and 2010 (4.44), with the probability of 
taking pharmaceutical drugs to treat this complaint be-
ing four times higher in 2010 than in 2006.
DISCUSSION
The use of medicines to treat common complaints, 
such as headache, stomachache, difficulty in getting 
to sleep and nervousness, is widespread among adoles-
cents and is increasing [1-4, 14]. Adolescence is a key 
period in human growth and health habits acquired in 
this period may be carried over into adulthood. Conse-
quently, adolescents constitute a strategic target group 
Table 1
Number of study subjects and prevalence of recurrent com-
plaints among 15-year-old adolescents by gender and survey: 
2006, 2010 and 2014 in Tuscany
2006
Gender Boys Girls Total p
N % N % N %
Total subjects 571 48.7 602 51.3 1173 100 >0.05
Headache 167 29.3 328 54.6 495 42.2 <0.01
Stomachache 123 21.6a 195 32.6b 318 27.2 <0.01
Difficult in 
get. sleep
115 20.1 160 26.6c 275 23.5d <0.01
Nervousness 338 59.5 455 75.8 794 67.9 <0.01
2010
Gender Boys Girls Total p
N % N % N %
Total subjects 468 51.9 433 48.1 901 100 >0.05
Headache 140 30.1 244 56.5 384 42.8 <0.01
Stomachache 95 20.6 179 41.5 274 30.7 <0.01
Difficult in 
get. sleep
95 20.4 144 33.3 239 26.6 <0.01
Nervousness 262 56.5 321 74.3 583 65.1 <0.01
2014
Gender Boys Girls Total p
N % N % N %
Total subjects 356 47.2 398 52.8 754 100 >0.05
Headache 97 27.5 244 61.9 341 45.6 <0.01
Stomachache 52 14.7a 153 38.8b 205 27.4 <0.01
Difficult in 
get. sleep
84 23.8 138 35.0c 222 29.7d <0.01
Nervousness 185 52.4 298 75.6 483 64.7 <0.01
a, b, c, d Bonferroni’s correction. In each complaint, where we see the same index, 
this means that there is a significant difference between those groups in 
multiple comparisons = p < 0.05. 
Chi-square: p < 0 .05.
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from a public point of view [10, 15].
The aim of our survey was to estimate the prevalence 
of recurrent specific complaints – headache, stomach-
ache, difficulty in getting to sleep and nervousness ± 
among 15-year-old adolescents and of medicine use to 
treat these complaints among boys and girls in Tuscany 
over three years (2006, 2010 and 2014).
Overall, the data revealed that girls displayed higher 
prevalence rates of all these complaints than boys over 
the three years (2006, 2010 and 2014), in accordance 
with other studies showing that gender differences in-
creased with age [6, 7, 16-18]. Girls showed an increase 
in headache, stomachache and difficulty in getting to 
sleep, while boys displayed a significant decrease in ner-
vousness and stomachache over the whole period.
As reported by other studies [1, 2, 7-9, 17, 18], the 
most common complaint for which adolescents use 
pharmaceutical remedies is headache. In our study, 
adolescents who suffered from headache were four/
five times more likely to use medicines than those with-
out headache, with no substantial differences between 
boys and girls. However, our data did not completely 
agree with those of other studies. Indeed, a study con-
ducted in 20 countries [1] found higher prevalence of 
the use of headache remedies among girls than boys, 
while another study reported a decline among girls be-
tween 1998 and 2010 [5]. Moreover, Andersen et al. [2] 
found an increase among girls aged 11- 15 years. The 
probability of using medicine to treat stomachache was 
three times higher among boys and girls who suffered 
from this complaint than among those who did not. 
Other studies have reported a greater use of stomach-
ache remedies among girls than among boys, increas-
ing with age [2, 5, 6, 8]. This difference could be due 
to menstruation, though no specific information on the 
type of stomachache is available [2, 5]. Only one study 
has reported a more likely use of medicine for stomach-
ache among boys than girls [7]. Additionally, the higher 
probability of using medicines to treat pain in adoles-
cents with recurrent pain than those without has been 
reported in other previous studies [6, 7, 19, 20]
In our survey, significant gender differences were seen 
in the use of medicines to treat sleep difficulties and 
nervousness. The data revealed that, in all years, girls 
with difficulty in getting to sleep were nine times more 
likely to use medicines than girls without this problem, 
while among boys the use of medicines was only four 
times greater. The same pattern emerged with regard 
Table 2 
The prevalence and odds ratio (95% CI) of medicine use for specific symptoms among 15-years-old adolescents, with recurrent 
complaints (in case of Trend), by gender and survey: 2006, 2010 and 2014
2006 2010 2014
Trend 
2006-
2010
Trend 
2010-
2014
Trend 
2006-
2014
% N OR
(95% CI)
% N OR
(95% CI)
% N OR
(95% CI)
OR
(95% CI)
OR
(95% CI)
OR
(95% CI)
Boys
Headache 53.6 89 3.45
(2.36-5.03)
55.1 76 4.79
(3.12-7.37)
50.5 48 4.54
(2.72-7.57)
1.06
(0.67-1.67)
0.83
(0.49-1.41)
0.84
(0.53-1.46)
Stomachache 28.5 35 2.21
(1.38-3.53)
31.2 29 3.24
(1.89-5.56)
26.9 14 2.86
(1.41-5.81)
1.14
(0.63-2.05)
0.81
(0.38-1.73)
0.93
(0.45-1.92)
Difficult in 
get. sleep
2.6 3 2.40
(0.56-10.17)
10.6 10 5.36
(2.05-13.99)
8.3 7 3.36
(1.14-9.89)
4.44
(1.19-16.65)
0.76
(0.28-2.11)
3.39
(0.85-13.54)
Nervousness 4.1 14 9.81
(1.28-75.12)
5.4 14 1.86
(0.70-4.93)
3.8 7 2.16
(0.55-8.50)
1.32
(0.62-2.81)
0.70
(0.28-1.76)
0.92
(0.36-2.31)
Girls
Headache 64.9 213 4.03
(2.86-5.67)
59.0 144 2.97
(2.00-4.43)
67.6 163 4.68
(3.01-7.27)
0.78
(0.55-1.09)
1.45
(1.01-2.10)
1.13
(0.79-1.61)
Stomachache 50.5 98 2.47
(1.74-3.53)
42.5 76 2.11
(1.40-3.18)
51.7 78 3.26
(2.11-5.03)
0.76
(0.48-1.09)
1.45
(0.94-2.24)
1.05
(0.68-1.60)
Difficult in 
get. sleep
9.4 15 11.20
(3.66-34.28)
9.8 14 15.47
(3.46-69.04)
9.5 13 4.30
(1.60-11.58)
1.05
(0.49-2.26)
0.97
(0.44-2.14)
1.01
(0.46-2.21)
Nervousness 6.0 27 9.13
(1.23-67.77)
7.2 23 8.52
(1.14-63.83)
9.9 29 10.40
(1.40-77.37)
1.22
(0.69-2.17)
1.41
(0.80-2.50)
1.73
(1.03-2.98)
Total
Headache 61.1 302 4.09
(3.20-5.24)
57.6 220 4.11
(3.09-5.46)
62.8 211 5.66
(4.11-7.80)
0.86
(0.66-1.13)
1.24
(0.92-1.68)
1.07
(0.81-1.43)
Stomachache 42.0 133 2.58
(1.96-3.41)
38.6 105 2.90
(2.11-4.00)
45.3 92 3.96
(2.77-5.65)
0.87
(0.63-1.21)
1.32
(0.91-1.91)
1.15
(0.80-1.64)
Difficult in 
get. sleep
6.5 18 6.86
(3.05-15.46)
10.1 24 7.27
(3.42-15.44)
9.0 20 3.87
(1.89-7.92)
1.61
(0.85-3.04)
0.88
(0.47-1.65)
1.49
(0.94-2.37)
Nervousness 5.2 41 10.15
(2.44-42.21)
6.4 37 2.98
(1.31-6.76)
7.5 36 5.27
(1.86-14.99)
1.25
(0.79-1.97)
1.20
(0.74-1.92)
1.42
(0.73-2.76)
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to nervousness; the probability of taking medicine to 
treat this complaint was ten times greater among girls 
and four times greater among boys than among their re-
spective counterparts who did not suffer from this prob-
lem. These data disagree with those of a previous study, 
which found only small gender differences in the use 
of medicine to treat both complaints [8]. Other stud-
ies have reported a decreased use of medicine for both 
complaints among boys and girls aged 11-15 years [8], 
particularly among boys [2, 5].
The limitation of this survey was the lack of specific 
information as proper drugs, types of stomachache in 
girls and the respondents’ parents’ social class. Previous 
studies found a positive correlation between the use of 
medicine and low parental social class, adolescents with 
low  sense of coherence, poor self-rated health and be-
ing a victim of bullying [14, 15, 21, 22].
Overall, our data showed that adolescents with re-
current headache, stomachache, difficulty in getting 
to sleep and nervousness were more likely to use medi-
cines highlighting significant gender differences to treat 
the last two complaints. In addition, girls used medi-
cines for pain more than boys [6, 8, 18].  This behavior 
could be linked to many factors, such as easy access 
to medicines (provided in part by parents), the avail-
ability of new medicines, changes in pharmaceutical 
regulations and more aggressive marketing [1, 5]. The 
use of medicines in adolescence is a public health con-
cern and constitutes an emerging issue that needs more 
attention and investigation on the part of scientific re-
search [7, 9, 23]. Adolescence is a key period in human 
growth, and health habits acquired in this period may 
be carried over into adulthood. Consequently, adoles-
cents should have adequate knowledge and awareness 
of medicine use.
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